Treatment of ovarian cancer cell lines with a recombinant fragment of human SP-D (rfhSP-D) led to decreased cell motility, inhibition of the mTOR pathway activity, and increased caspase 3 cleavage and pro-apoptotic genes Fas and TNF-α (22, 113, 119). Here, SFTPD is linked to ovarian carcinoma.